Figure 1.
Breast cancer-specific progression-free survival of 196 TNBC patients according to the presence or absence of the CCND1 rs614367-T allele (A) and specific 10-years overall survival of 163 TNBC patients from the TCGA dataset according to the presence or absence of MAP3K21 rs1284255-G allele (B).